Q2 earnnigs report and conference call is tomorrow. This should provide some interesting insight into where things are right now, although FDA approval of Zenvia is still the linchpin here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.